Inventiva S.A. IVA
4.12 USD +0.29 (+7.44%)
Nov 3, 2026, 3:27 PM EST
3.78 Day range 4.17
2.82 52-week range 7.29
- YTD
- -11.51%
- 1 year
- +0.37%
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 14.62 +255.4% upside
Now 4.12
- Target (low)
- 8.80
- Target (mean)
- 14.62
- Target (high)
- 26.00
Ratings (0m) 12 12 buy · 0 hold · 0 sell
- Strong buy1
- Buy11
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 12
- 1 month ago 13
- 2 months ago 13
- 3 months ago 13
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 0 | 0.0% | 0 |
| Next quarter | -0.20 | -0.20 – -0.20 | 0.00 | 0.0% | 3.06M | 0.0% | 1 |
| Current year | -0.80367 | -0.917 – -0.67 | -2.18 | +63.1% | 7.41M | +65.3% | 6 |
| Next year | -0.83283 | -1.17 – -0.499 | -0.80367 | -3.6% | 109.21M | +1374.0% | 6 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Jul 17, 2026 | Cantor Fitzgerald | Initiated | — | Overweight |
| Mar 19, 2026 | Truist Securities | Initiated | — | Buy |
| Jan 28, 2026 | Barclays | Initiated | — | Overweight |
| Jan 12, 2026 | Leerink Partners | Initiated | — | Outperform |
| Nov 18, 2025 | Guggenheim | Maintained | Buy | Buy |
| Nov 6, 2025 | Wolfe Research | Initiated | — | Outperform |
| Oct 9, 2025 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Sep 30, 2025 | Canaccord Genuity | Maintained | Buy | Buy |
| Sep 2, 2025 | Guggenheim | Maintained | Buy | Buy |
| Aug 27, 2025 | Piper Sandler | Initiated | — | Overweight |
| Apr 4, 2025 | Guggenheim | Maintained | Buy | Buy |
| Apr 2, 2025 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Mar 28, 2025 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jan 30, 2025 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Nov 22, 2024 | Stifel | Maintained | Buy | Buy |
| Nov 12, 2024 | UBS | Initiated | — | Neutral |
| Oct 15, 2024 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Sep 26, 2024 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Sep 26, 2024 | Stifel | Maintained | Buy | Buy |
| Apr 8, 2024 | Canaccord Genuity | Maintained | Buy | Buy |
| Apr 1, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Mar 20, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Mar 8, 2024 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Feb 16, 2024 | Stifel | Maintained | Buy | Buy |
| Dec 21, 2023 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Oct 27, 2023 | Canaccord Genuity | Initiated | — | Buy |
| Sep 21, 2023 | Roth MKM | Reiterated | Buy | Buy |
| Sep 1, 2023 | Guggenheim | Reiterated | Buy | Buy |
| Jul 28, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jun 16, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |